摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(3-oxopropyl)-2-phenylacetamide | 151068-17-6

中文名称
——
中文别名
——
英文名称
N-(3-oxopropyl)-2-phenylacetamide
英文别名
——
N-(3-oxopropyl)-2-phenylacetamide化学式
CAS
151068-17-6
化学式
C11H13NO2
mdl
MFCD11610860
分子量
191.23
InChiKey
BCCHAYAYBSUKNO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    411.5±38.0 °C(Predicted)
  • 密度:
    1.092±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.6
  • 重原子数:
    14
  • 可旋转键数:
    5
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.272
  • 拓扑面积:
    46.2
  • 氢给体数:
    1
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    [EN] COMPOSITIONS AND METHODS FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS
    [FR] COMPOSITIONS ET PROCÉDÉS POUR LE TRAITEMENT DU VIRUS DE L'IMMUNODÉFICIENCE HUMAINE
    摘要:
    公开号:
    WO2020252393A8
  • 作为产物:
    描述:
    N-(3-hydroxypropyl)-2-phenylacetamide2-亚碘酰基苯甲酸 作用下, 以 二甲基亚砜 为溶剂, 以52%的产率得到N-(3-oxopropyl)-2-phenylacetamide
    参考文献:
    名称:
    Influence of N-amino protecting group on aldolase-catalyzed aldol additions of dihydroxyacetone phosphate to amino aldehydes
    摘要:
    This work examines the influence of N-protecting groups on the conversion and stereoselectivity of dihydroxy acetone phosphate (DHAP) dependent aldolase-catalyzed aldol additions of DHAP to N-protected-3-aminopropanal. Phenylacetyl-(PhAc-), tertbutyloxycarbonyl- ((t)Boc-) and fluoren-9-ylmethoxycarbonyl- (Fmoc-)-3-aminopropanal were evaluated as substrates for D-fructose 1,6-bisphosphate aldolase from rabbit muscle (RAMA), and L-rhamnulose-1-phosphate aldolase (RhuA) and L-fuculose-1-phosphate aldolase (FucA), both from Escherichia coli. Using PhAc and (t)Boc ca. 70% conversions to the aldol adduct were achieved, whereas Fmoc gave maximum conversions of ca. 25%. The stereoselectivity of the DHAP-aldolases did not depend on the N-protected-3-aminopropanal derivative. Moreover, inversion of FucA stereoselectivity relative to that obtained with the natural L-lactaldehyde was observed. Both N-PhAc and (t)Boc adduct product derivatives were successfully deprotected by penicillin G acylase (PGA)-catalyzed hydrolysis at pH 7 and by treatment with aqueous TFA (6% v/v), respectively. However, the corresponding cyclic imine sugars could not be isolated, presumable due to the presence of a highly reactive primary amine and a keto group in the molecule, which lead to a number of unexpected reactions. (c) 2005 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tet.2005.12.031
点击查看最新优质反应信息

文献信息

  • Selectively Tunable Synthesis of α-Trifluoromethyl Ketones
    作者:Pan Zhou、Shanya Lu、Xiaoqiang Wu、Wei Zhong、Tao XU
    DOI:10.1021/acs.orglett.3c00725
    日期:——
    catalysis system. A wide variety of substrates bearing a diverse set of functional groups were compatible to afford α-trifluoromethyl ketones under very mild conditions (visible light, ambient temperature, no strong base). Selectively tunable access to these ketones with the trifluoromethyl group on any one side can be smoothly obtained by simply modulating different reagents. Meanwhile, the asymmetric
    通过双/光氧化还原催化系统开发了醛和 α-三甲基烷基的交叉偶联。在非常温和的条件下(可见光、环境温度、无强碱),带有不同官能团的多种底物相容以提供 α-三甲基酮。通过简单地调节不同的试剂,可以顺利地获得在任何一侧具有三甲基的这些酮的选择性可调访问。同时,还研究了不对称图案。
  • Photocatalytic Synthesis of Acetals and Ketals from Aldehydes and Silylenolethers without the Use of Acids
    作者:Desirée Steuernagel、Hans‐Achim Wagenknecht
    DOI:10.1002/chem.202203767
    日期:2023.3
    Use light instead of acids: Silylenolethers derived from aldehydes and ketones as well as aldehydes themselves react efficiently to give acetals in good to excellent yields. The substrate range with respect to both aldehydes and alcohols is broad, and acid- and hydrogen-labile protecting groups are tolerated.
    使用光而不是酸:从醛和酮衍生的甲硅烷基醚以及醛本身可以有效地反应,以良好到极好的收率生成缩醛醛类醇类的底物范围很广,可以接受酸和氢不稳定的保护基团。
  • Beta-lactamase inhibitory composition
    申请人:Takeda Chemical Industries, Ltd.
    公开号:EP0050965A1
    公开(公告)日:1982-05-05
    Compounds having one or two substituents at the 3- position, represented by the general formula wherein R, is an optionally acylated or protected amino group and X is hydrogen atom or methoxy group, or a pharmaceutically acceptable salt thereof; when used either alone or in combination with a β-lactam antibiotic, show excellent β-lactamase inhibitory activity and can be used as drugs for use in humans and domestic animals.
    在 3-位上有一个或两个取代基的化合物,由通式表示,其中 R 是可选的酰化或保护基,X 是氢原子或甲氧基,或其药学上可接受的盐;当单独使用或与β-内酰胺类抗生素结合使用时,可显示出优异的β-内酰胺酶抑制活性,可用作人类和家畜的药物。
  • [EN] MODULATORS OF REV-ERB<br/>[FR] MODULATEURS DE REV-ERB
    申请人:KAMENECKA THEODORE MARK
    公开号:WO2013033310A1
    公开(公告)日:2013-03-07
    The subject matter herein concerns the identification and development of potent synthetic REV-ERB ligands, such as in vivo agonists and antagonists. These compounds allow for characterization of the effects of modulation of this receptor in vivo specifically on circadian behavior and metabolism, and have suitable characteristics for development of medicinal compounds useful for treatment of malconditions such as diabetes, obesity, atherosclerosis, dyslipidemia, a circadian rhythm disorder, coronary artery disease, bipolar disorder, depression, cancer, a sleep disorder, an anxiety disorder, an addiction disorder, or an autoimmune disorder.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫